RANO 2.0 incorporates an integrated quantitative assessment of both enhancing ... Wen, MD, Director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute. Details for the RANO 2.0 ...
Planegg/Martinsried, November 11, 2024.Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused ...
Because this plan is a short plan based on a test of resistance it is referred to as a Short Resistance Plan. Check the time ...
From cutting-edge treatment methods to the integration of new technologies, the International Conference on Advances in Radiation Oncology (ICARO-4) promises to inspire and equip conference attendees ...
Fulgent Genetics is transitioning toward becoming a fully integrated precision medicine company. This strategic shift focuses ...
IHH Healthcare, a leading integrated healthcare provider, has finalised its acquisition of Island Hospital, a 600-bed facility in Penang ...
At Greenwich Hospital, Oh will continue to develop integrated oncology care teams and expand the impact of multidisciplinary ...
DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.
Dr. William Oh is the new medical director of Smilow Cancer Hospital at Greenwich Hospital. Photo courtesy of Yale Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback